Annual Total Debt
$46.59 M
+$39.81 M+587.40%
31 December 2023
Summary:
Inozyme Pharma annual total debt is currently $46.59 million, with the most recent change of +$39.81 million (+587.40%) on 31 December 2023. During the last 3 years, it has risen by +$45.30 million (+3520.20%). INZY annual total debt is now at all-time high.INZY Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$46.79 M
+$82.00 K+0.18%
30 September 2024
Summary:
Inozyme Pharma quarterly total debt is currently $46.79 million, with the most recent change of +$82.00 thousand (+0.18%) on 30 September 2024. Over the past year, it has increased by +$12.69 million (+37.22%). INZY quarterly total debt is now at all-time high.INZY Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INZY Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +587.4% | +37.2% |
| 3 y3 years | +3520.2% | +1221.8% |
| 5 y5 years | +100.0% | +100.0% |
INZY Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +3520.2% | at high | +1453.0% |
| 5 y | 5 years | at high | at high | ||
| alltime | all time | at high | at high |
Inozyme Pharma Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $46.79 M(+0.2%) |
| June 2024 | - | $46.71 M(+0.2%) |
| Mar 2024 | - | $46.63 M(+0.1%) |
| Dec 2023 | $46.59 M(+587.4%) | $46.59 M(+36.6%) |
| Sept 2023 | - | $34.10 M(-0.0%) |
| June 2023 | - | $34.12 M(+28.0%) |
| Mar 2023 | - | $26.66 M(+293.3%) |
| Dec 2022 | $6.78 M(+101.1%) | $6.78 M(-1.8%) |
| Sept 2022 | - | $6.90 M(+129.1%) |
| June 2022 | - | $3.01 M(-5.7%) |
| Mar 2022 | - | $3.19 M(-5.3%) |
| Dec 2021 | $3.37 M | $3.37 M(-4.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $3.54 M(-4.4%) |
| June 2021 | - | $3.70 M(-4.2%) |
| Mar 2021 | - | $3.87 M(+200.4%) |
| Dec 2020 | $1.29 M(>+9900.0%) | $1.29 M(>+9900.0%) |
| Sept 2020 | - | $0.00(0.0%) |
| June 2020 | - | $0.00(0.0%) |
| Mar 2020 | - | $0.00(0.0%) |
| Dec 2019 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2019 | - | $0.00(0.0%) |
| June 2019 | - | $0.00(0.0%) |
| Mar 2019 | - | $0.00 |
| Dec 2018 | $0.00 | - |
FAQ
- What is Inozyme Pharma annual total debt?
- What is the all time high annual total debt for Inozyme Pharma?
- What is Inozyme Pharma annual total debt year-on-year change?
- What is Inozyme Pharma quarterly total debt?
- What is the all time high quarterly total debt for Inozyme Pharma?
- What is Inozyme Pharma quarterly total debt year-on-year change?
What is Inozyme Pharma annual total debt?
The current annual total debt of INZY is $46.59 M
What is the all time high annual total debt for Inozyme Pharma?
Inozyme Pharma all-time high annual total debt is $46.59 M
What is Inozyme Pharma annual total debt year-on-year change?
Over the past year, INZY annual total debt has changed by +$39.81 M (+587.40%)
What is Inozyme Pharma quarterly total debt?
The current quarterly total debt of INZY is $46.79 M
What is the all time high quarterly total debt for Inozyme Pharma?
Inozyme Pharma all-time high quarterly total debt is $46.79 M
What is Inozyme Pharma quarterly total debt year-on-year change?
Over the past year, INZY quarterly total debt has changed by +$12.69 M (+37.22%)